ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,498Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 464

$547K Total Retail Price of All Prescriptions

Rank: 6 out of 464

648 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 648 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

2% of this provider’s 648 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 9,803 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 722 678 1 3
LISINOPRIL 603 558 2 1
WARFARIN SODIUM 521 492 3 8
ATENOLOL 470 451 4 9
FUROSEMIDE 467 460 5 5
ISOSORBIDE MONONITRATE ER 381 347 6 12
METOPROLOL TARTRATE 311 279 7 4
OMEPRAZOLE 242 196 8 18
AMLODIPINE BESYLATE 238 230 9 6
DIOVAN 215 210 10 20
ATORVASTATIN CALCIUM 206 183 11 7
METFORMIN HCL 202 189 12 22
METOPROLOL SUCCINATE 192 175 13 2
DIGOXIN 191 191 14 14
CLOPIDOGREL 159 144 15 17
LEVOTHYROXINE SODIUM 153 153 16 19
QUINAPRIL HCL 150 147 17 54
PAROXETINE HCL 118 114 18 80
HYDROCHLOROTHIAZIDE 118 118 18 10
ALLOPURINOL 107 107 20 35
PRAVASTATIN SODIUM 94 93 21 15
TRAMADOL HCL 93 84 22 55
ADVAIR DISKUS 92 86 23 76
VERAPAMIL ER 91 91 24 58
TRAZODONE HCL 90 90 25 45
CITALOPRAM HBR 88 72 26 31
AMILORIDE-HYDROCHLOROTHIAZIDE 87 85 27 140
PLAVIX 87 82 27 21
EXELON 87 87 27 140
POTASSIUM CHLORIDE 85 70 30 40
DILTIAZEM 24HR ER 75 75 31 23
CARVEDILOL 71 69 32 11
DILTIAZEM 24HR CD 65 65 33 53
MIRTAZAPINE 63 63 34 65
FLUTICASONE PROPIONATE 63 63 34 73
NEXIUM 62 38 36 101
NIFEDIPINE ER 62 55 36 63
RANITIDINE HCL 62 37 36 48
CIPROFLOXACIN HCL 62 56 36 98
ZOLPIDEM TARTRATE 60 54 40 37
NAMENDA 60 60 40 88
SPIRIVA 59 59 42 81
PANTOPRAZOLE SODIUM 58 57 43 36
SERTRALINE HCL 56 55 44 50
CRESTOR 56 56 44 13
LIPITOR 56 50 44 26
NITROSTAT 55 48 47 24
DIOVAN HCT 55 47 47 83
HYDRALAZINE HCL 54 54 49 56
LOSARTAN POTASSIUM 53 52 50 16
COMBIVENT 50 50 51 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.